Lathrop Investment Management Corp maintained its stake in shares of Laboratory Corp. of America Holdings (NYSE:LH) during the third quarter, Holdings Channel reports. The firm owned 13,355 shares of the company’s stock at the end of the third quarter. Laboratory Corp. of America Holdings makes up about 0.5% of Lathrop Investment Management Corp’s portfolio, making the stock its 28th largest position. Lathrop Investment Management Corp’s holdings in Laboratory Corp. of America Holdings were worth $1,740,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Oppenheimer & Co. Inc. increased its stake in shares of Laboratory Corp. of America Holdings by 0.4% in the second quarter. Oppenheimer & Co. Inc. now owns 2,396 shares of the company’s stock valued at $312,000 after buying an additional 9 shares during the period. Concert Wealth Management Inc. increased its stake in shares of Laboratory Corp. of America Holdings by 0.4% in the second quarter. Concert Wealth Management Inc. now owns 2,393 shares of the company’s stock valued at $313,000 after buying an additional 10 shares during the period. Raymond James Trust N.A. increased its stake in shares of Laboratory Corp. of America Holdings by 0.4% in the third quarter. Raymond James Trust N.A. now owns 2,484 shares of the company’s stock valued at $341,000 after buying an additional 10 shares during the period. Cleararc Capital Inc. increased its stake in shares of Laboratory Corp. of America Holdings by 0.8% in the second quarter. Cleararc Capital Inc. now owns 2,494 shares of the company’s stock valued at $325,000 after buying an additional 20 shares during the period. Finally, Northwestern Mutual Investment Management Company LLC increased its stake in shares of Laboratory Corp. of America Holdings by 0.6% in the second quarter. Northwestern Mutual Investment Management Company LLC now owns 3,905 shares of the company’s stock valued at $509,000 after buying an additional 22 shares during the period. Institutional investors and hedge funds own 91.24% of the company’s stock.

Institutional Ownership by Quarter for Laboratory Corp. of America Holdings (NYSE:LH)

Laboratory Corp. of America Holdings (NYSE:LH) traded up 1.60% during mid-day trading on Tuesday, reaching $127.72. 459,017 shares of the company’s stock traded hands. The firm has a 50 day moving average of $129.54 and a 200 day moving average of $133.00. Laboratory Corp. of America Holdings has a 1-year low of $97.79 and a 1-year high of $141.32. The firm has a market cap of $13.16 billion, a PE ratio of 20.25 and a beta of 0.96.

Laboratory Corp. of America Holdings (NYSE:LH) last announced its quarterly earnings data on Wednesday, October 26th. The company reported $2.25 EPS for the quarter, missing the Zacks’ consensus estimate of $2.29 by $0.04. The business earned $2.40 billion during the quarter, compared to the consensus estimate of $2.38 billion. Laboratory Corp. of America Holdings had a return on equity of 16.97% and a net margin of 6.85%. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.07 EPS. Analysts forecast that Laboratory Corp. of America Holdings will post $8.78 EPS for the current year.

TRADEMARK VIOLATION WARNING: “Lathrop Investment Management Corp Has $1,740,000 Position in Laboratory Corp. of America Holdings (LH)” was posted by Daily Political and is owned by of Daily Political. If you are accessing this article on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The correct version of this article can be viewed at http://www.dailypolitical.com/2016/11/29/lathrop-investment-management-corp-has-1740000-position-in-laboratory-corp-of-america-holdings-lh.html.

A number of equities research analysts have issued reports on the stock. Canaccord Genuity set a $140.00 target price on shares of Laboratory Corp. of America Holdings and gave the stock a “buy” rating in a research report on Sunday, October 30th. Citigroup Inc. assumed coverage on shares of Laboratory Corp. of America Holdings in a research report on Friday, September 9th. They issued a “neutral” rating and a $156.00 target price for the company. They noted that the move was a valuation call. Zacks Investment Research downgraded shares of Laboratory Corp. of America Holdings from a “buy” rating to a “hold” rating in a research report on Friday, August 19th. KeyCorp increased their target price on shares of Laboratory Corp. of America Holdings from $143.00 to $150.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 16th. Finally, Barclays PLC set a $155.00 target price on shares of Laboratory Corp. of America Holdings and gave the stock a “buy” rating in a research report on Monday, August 29th. Eight analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $143.13.

About Laboratory Corp. of America Holdings

Laboratory Corporation of America Holdings is a healthcare diagnostics company. The Company, together with its subsidiaries, is engaged in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

5 Day Chart for NYSE:LH

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Corp. of America Holdings (NYSE:LH).

Receive News & Ratings for Laboratory Corp. of America Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corp. of America Holdings and related companies with MarketBeat.com's FREE daily email newsletter.